Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells

Author：              

Publisher： Spandidos Publications

E-ISSN： 1791-2431|35|2|992-998

ISSN： 1021-335X

Source： Oncology Reports, Vol.35, Iss.2, 2016-01, pp. : 992-998

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

By Moriyama Takuzou   Kataoka Hiroaki   Hamasuna Ryouichi   Yoshida Etsuo   Sameshima Tetsuro   Iseda Tsutomu   Yokogami Kiyotaka   Nakano Shinichi   Koono Masashi   Wakisaka Shinichiro  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 873-879

Springer Publishing Company

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer

By Tecimer C.   Doering D.L.   Goldsmith L.J.   Meyer J.S.   Abdulhay G.   Wittliff J.L.  

Gynecologic Oncology, Vol. 80, Iss. 1, 2001-01 ,pp. : 48-55

Elsevier

Access to resources Recommend Favorite

Cadmium induces urokinase-type plasminogen activator receptor expression and the cell invasiveness of human gastric cancer cells via the ERK-1/2, NF-κB, and AP-1 signaling pathways

By                  

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1760-1768

Spandidos Publications

Access to resources Recommend Favorite

Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions

By Daneri-Navarro A.   Macias-Lopez G.   Oceguera-Villanueva A.   Del Toro-Arreola S.   Bravo-Cuellar A.   Perez-Montfort R.   Orbach-Arbouys S.  

European Journal of Cancer, Vol. 34, Iss. 4, 1998-03 ,pp. : 566-569

Elsevier

Access to resources Recommend Favorite